共有 50 笔近期内部人交易记录记录，涉及 HOOKIPA Pharma Inc. (HOOK), 包括 44 笔买入 和 2 笔卖出. 内部人买入总额为 $4.56M 内部人卖出总额为 $29.48K.
近期活跃的重要内部人包括 Cassidy Sean A, Coelho Mary Theresa, Peters Malte. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — HOOK
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-07-22 |
Cassidy Sean A |
Officer |
未知 |
- |
- |
- |
- |
| 2024-07-22 |
Cassidy Sean A |
Director |
限制性股票授予 (RSU) |
9,800 |
$6.44 |
$63.11K |
9,800 |
| 2024-07-22 |
Coelho Mary Theresa |
EVP and CFO |
限制性股票授予 (RSU) |
69,875 |
- |
- |
69,875 |
| 2024-07-22 |
Peters Malte |
Chief Executive Officer |
限制性股票授予 (RSU) |
108,695 |
- |
- |
108,695 |
| 2024-06-17 |
O'neill Julie |
Director |
限制性股票授予 (RSU) |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Coelho Mary Theresa |
Director |
限制性股票授予 (RSU) |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Van De Winkel Jan |
Director |
限制性股票授予 (RSU) |
98,000 |
$0.71 |
$69.58K |
98,000 |
| 2024-06-17 |
Kaufman David Ross |
Director |
限制性股票授予 (RSU) |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Peters Malte |
Director |
限制性股票授予 (RSU) |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Reilly Timothy P. |
Director |
限制性股票授予 (RSU) |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-04-15 |
Aldag Jorn |
Chief Executive Officer |
限制性股票授予 (RSU) |
971,400 |
$0.76 |
$738.26K |
971,400 |
| 2024-04-15 |
Kandera Reinhard |
Chief Financial Officer |
限制性股票授予 (RSU) |
406,200 |
$0.76 |
$308.71K |
406,200 |
| 2024-04-15 |
Orlinger Klaus |
Chief Scientific Officer |
限制性股票授予 (RSU) |
367,300 |
$0.76 |
$279.15K |
367,300 |
| 2024-04-15 |
Necina Roman |
Chief Operations Officer |
限制性股票授予 (RSU) |
367,300 |
$0.76 |
$279.15K |
367,300 |
| 2024-04-15 |
Winderlich Mark |
Chief Development Officer |
限制性股票授予 (RSU) |
50,000 |
$0.76 |
$38K |
50,000 |
| 2024-04-01 |
Winderlich Mark |
Officer |
未知 |
- |
- |
- |
- |
| 2023-12-20 |
Gilead Sciences, Inc. |
10 Percent Owner |
处置 |
- |
- |
- |
18,759,465 |
| 2023-08-21 |
Kandera Reinhard |
Chief Financial Officer |
知情买入 |
7,000 |
$0.73 |
$5.08K |
43,092 |
| 2023-08-16 |
Kandera Reinhard |
Chief Financial Officer |
知情买入 |
8,000 |
$0.71 |
$5.71K |
36,092 |
| 2023-07-11 |
Aldag Jorn |
Chief Executive Officer |
知情买入 |
5,000 |
$0.83 |
$4.14K |
71,952 |
| 2023-07-07 |
Aldag Jorn |
Chief Executive Officer |
知情买入 |
5,000 |
$0.81 |
$4.05K |
66,952 |
| 2023-07-05 |
Aldag Jorn |
Chief Executive Officer |
知情买入 |
5,000 |
$0.89 |
$4.45K |
61,952 |
| 2023-07-03 |
Aldag Jorn |
Chief Executive Officer |
知情买入 |
5,000 |
$0.89 |
$4.46K |
56,952 |
| 2023-06-30 |
Kandera Reinhard |
Chief Financial Officer |
知情买入 |
12,000 |
$0.88 |
$10.56K |
28,092 |
| 2023-06-09 |
O'neill Julie |
Director |
限制性股票授予 (RSU) |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-06-09 |
Coelho Mary Theresa |
Director |
限制性股票授予 (RSU) |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Van De Winkel Jan |
Director |
限制性股票授予 (RSU) |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Kaufman David Ross |
Director |
限制性股票授予 (RSU) |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-06-09 |
Peters Malte |
Director |
限制性股票授予 (RSU) |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Reilly Timothy P. |
Director |
限制性股票授予 (RSU) |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-04-14 |
Aldag Jorn |
Chief Executive Officer |
限制性股票授予 (RSU) |
513,600 |
$1.00 |
$513.6K |
513,600 |
| 2023-04-14 |
Kandera Reinhard |
Chief Financial Officer |
限制性股票授予 (RSU) |
214,800 |
$1.00 |
$214.8K |
214,800 |
| 2023-04-14 |
Orlinger Klaus |
Chief Scientific Officer |
限制性股票授予 (RSU) |
194,200 |
$1.00 |
$194.2K |
194,200 |
| 2023-04-14 |
Necina Roman |
Chief Development Officer |
限制性股票授予 (RSU) |
112,100 |
$1.00 |
$112.1K |
112,100 |
| 2023-04-14 |
Baker Christine D. |
Chief Operating Officer |
限制性股票授予 (RSU) |
275,800 |
$1.00 |
$275.8K |
275,800 |
| 2023-04-14 |
Schlienger Katia |
Chief Medical Officer |
限制性股票授予 (RSU) |
184,000 |
$1.00 |
$184K |
184,000 |
| 2023-04-03 |
Coelho Mary Theresa |
Director |
未知 |
- |
- |
- |
- |
| 2023-03-09 |
Schlienger Katia |
Chief Medical Officer |
处置 |
17,760 |
$1.66 |
$29.48K |
- |
| 2023-01-01 |
Peters Malte |
Director |
未知 |
- |
- |
- |
- |
| 2022-06-30 |
O'neill Julie |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Aldag Jorn |
Chief Executive Officer |
限制性股票授予 (RSU) |
275,250 |
$1.66 |
$456.92K |
275,250 |
| 2022-06-30 |
Van De Winkel Jan |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.63 |
$65.2K |
40,000 |
| 2022-06-30 |
Matushansky Igor |
Chief Medical Officer |
限制性股票授予 (RSU) |
92,950 |
- |
- |
92,950 |
| 2022-06-30 |
Kandera Reinhard |
Chief Financial Officer |
限制性股票授予 (RSU) |
92,950 |
$1.66 |
$154.3K |
92,950 |
| 2022-06-30 |
Orlinger Klaus |
Chief Scientific Officer |
限制性股票授予 (RSU) |
48,350 |
$1.66 |
$80.26K |
48,350 |
| 2022-06-30 |
Kelly Michael Aaron |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Kaufman David Ross |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Necina Roman |
Chief Technology Officer |
限制性股票授予 (RSU) |
48,350 |
$1.66 |
$80.26K |
48,350 |
| 2022-06-30 |
Baker Christine D. |
Chief Operating Officer |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2022-06-30 |
Reilly Timothy P. |
Director |
限制性股票授予 (RSU) |
40,000 |
- |
- |
40,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
